United States · Series A startup

Who invested in AnTolRx

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$4.0Mraised across 1 round since 2016, from 1 source

Latest round
Series A, $4.0MSept 2016
Investors
1
See who backed them

The rounds

  1. Sept 2016
    Series A$4.0M

    Reported by FinSMEsSEC filing: $1.0M sold, first sale Jun 2016

Everyone who backed them

PfizerCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about AnTolRx

Who invested in AnTolRx?

AnTolRx's investors include Pfizer.

How much has AnTolRx raised?

AnTolRx has raised $4.0M across 1 round since 2016.

When did AnTolRx last raise?

AnTolRx's most recent round was a Series A of $4.0M in Sept 2016.

What was AnTolRx's biggest round?

Its most recent round, $4.0M in Sept 2016, is also its largest on record.

Who backed AnTolRx first?

AnTolRx's first round on record, in Sept 2016, was backed by Pfizer.

What stage is AnTolRx at?

AnTolRx's latest named round is a Series A, in Sept 2016.

Where is AnTolRx based?

AnTolRx is based in the United States.

Companies like AnTolRx

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.